134 related articles for article (PubMed ID: 3383986)
1. Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin.
Preiss R; Brovtsyn VK; Perevodchikova NI; Bychkov MB; Hüller H; Belova LA; Michailov P
Eur J Clin Pharmacol; 1988; 34(2):139-44. PubMed ID: 3383986
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of plasma platinum in a hemodialysis patient receiving repeated doses of cisplatin.
Hirai K; Ishiko O; Sumi T; Kanaoka Y; Ogita S
Oncol Rep; 2000; 7(6):1243-5. PubMed ID: 11032923
[TBL] [Abstract][Full Text] [Related]
3. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
Uozumi J; Litterst CL
J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimens.
Gandara DR; Perez EA; Denham A; Wiebe VJ; DeGregorio MW
Cancer Chemother Pharmacol; 1989; 24(2):135-6. PubMed ID: 2786459
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin pharmacokinetics in children with cancer.
Peng B; English MW; Boddy AV; Price L; Wyllie R; Pearson AD; Tilby MJ; Newell DR
Eur J Cancer; 1997 Oct; 33(11):1823-8. PubMed ID: 9470840
[TBL] [Abstract][Full Text] [Related]
6. The treatment of advanced bladder cancer with methotrexate and cis-platinum--a pharmacokinetic study.
Kaye SB; McWhinnie D; Hart A; Deane RF; Billaert P; Welsh J; Milsted RV; Stuart JF; Calman KC
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):249-52. PubMed ID: 6368243
[TBL] [Abstract][Full Text] [Related]
7. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
Dumas M; de Gislain C; d'Athis P; Chadoint-Noudeau V; Escousse A; Guerrin J; Autissier N
Cancer Chemother Pharmacol; 1989; 23(1):37-40. PubMed ID: 2909288
[TBL] [Abstract][Full Text] [Related]
10. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II).
Reece PA; Stafford I; Russell J; Gill PG
Cancer Chemother Pharmacol; 1985; 15(3):295-9. PubMed ID: 4053272
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity].
Kitajima K; Fukuoka M; Kobayashi S; Kusunoki Y; Takada M; Negoro S; Matsui K; Sakai N; Ryu S; Takifuji N
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2517-23. PubMed ID: 3039920
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of platinum in cancer patients treated with carboplatin in combination with high-dose methotrexate.
el-Yazigi A; Amer M; Martin CR
Pharm Res; 1989 Jun; 6(6):492-6. PubMed ID: 2668915
[TBL] [Abstract][Full Text] [Related]
15. Reduced ability to clear ultrafilterable platinum with repeated courses of cisplatin.
Reece PA; Stafford I; Russell J; Gill PG
J Clin Oncol; 1986 Sep; 4(9):1392-8. PubMed ID: 3746376
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
Vermorken JB; van der Vijgh WJ; Klein I; Hart AA; Gall HE; Pinedo HM
Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of high-dose cisplatin in children: pharmacokinetics of free and total platinum.
Bues-Charbit M; Gentet JC; Bernard JL; Breant V; Cano JP; Raybaud C
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1649-52. PubMed ID: 3428333
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy].
Tokunaga J; Kikukawa H; Nishi K; Kitani K; Fujii J; Honda J; Wada Y; Ueda S; Nakano M
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2079-85. PubMed ID: 11103239
[TBL] [Abstract][Full Text] [Related]
19. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
[TBL] [Abstract][Full Text] [Related]
20. Atypical pharmacokinetics and excretion of new platinum analogues in rodents.
Webster LK; Ellis AG; Apicella C; Deacon GB
Cancer Chemother Pharmacol; 2002 Jan; 49(1):87-92. PubMed ID: 11855757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
